Open AccessFeatures and risk factors for new (secondary) permanent visual involvement in giant cell arteritis
Author(s) -
Muhammad Faiz Curumthaullee,
É. Liozon,
Stéphanie Dumonteil,
G. Gondran,
AnneLaure Fauchais,
KimHeang Ly,
Pierre-Yves Robert,
Simon Parreau
Publication year - 2022
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/btj1ia
Subject(s) - medicine , giant cell arteritis , cohort , glucocorticoid , surgery , population , arteritis , vasculitis , disease , environmental health
New permanent visual loss (PVL) in treated patients with giant cell arteritis (GCA) is a rare but worrisome occurrence. In this study, we aimed to describe the frequency and main features of new PVL occurring after the beginning of glucocorticoid therapy in patients with newly diagnosed GCA.